Dr. Niranjan Kumar, Ph.D. Executive Masters in Technology Management
Dr. Kumar is a member of board of advisors of The Varhad Group.
Dr. Kumar is currently Chairman and CEO of ABS Novacell Ltd.
He has a PhD in Biochemistry & Microbiology, Executive Masters in Technology Management (Pen Eng & Wharton Business School, UPenn) and has 25 years of extensive experience in Biologics (novel vaccines) & Biotherapeutics (Proteins & Monoclonal Antibodies) & Blood Plasma Products.
has founded 2 companies in the US (American Bio Sources Inc.
Innovative Biopharmaceutical Products company & ABSINCGROUP
- Strategic Management Consulting & Services) and one non-profit Organization in the US (Global Bio Pharma Conference Group).
has held numerous senior management positions such as Senior VP, Wockhardt Biotech Strategic Business Unit, Executive Director
, Novavax Inc.
Director in Sanofi-Aventis, Group Leader Wyeth
(Pfizer, USA) and Merck & Co.
Inc. USA and managed multi-billion dollars budgets, projects, P &L and people and various sites in the World.
Prior to that Dr. Kumar was Asst.
Professor of Medicine, Pulmonary Critical Care/Lung Biology, State University of New York
, Buffalo, NY and Post Doctoral Fellow in SUNY
@ Buffalo and University of Rochester Medical School
, Rochester, NY.
has contributed numerous block buster drugs launch and published numerous peer reviewed papers and presented in numerous International Conferences.
Dr.Kumar brought US $ 200M LOI from EXIM bank for renewable energy projects.